Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer

• मुख्य लेखकों: Ananaya Datta-Mitra (लेखक), Navdeep K Riar (लेखक), Siba P Raychaudhuri (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wolters Kluwer Medknow Publications, 2014-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), is employed for treatment of several cancers and retinopathies. Although previous reports of remission of psoriasis with bevacizumab do exist, but its current experience for psoriatic arthritis (PsA) is still limit...